Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04541173
Title Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aiwu Ruth He, MD
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Washington District of Columbia 20057 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
Boston Medical Center Boston Massachusetts 02118 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from for the field